Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 473

1.

In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis.

Vabanesi M, Pisa M, Guerrieri S, Moiola L, Radaelli M, Medaglini S, Martinelli V, Comi G, Leocani L.

Sci Rep. 2019 Jul 17;9(1):10371. doi: 10.1038/s41598-019-46251-3.

2.

[The study of the personality of a potential case of samaritan donation].

De Pasquale C, Pistorio ML, Veroux M, Cottone PM, Martinelli V, Giaquinta A, Veroux P.

G Ital Nefrol. 2019 Jun 11;36(3). pii: 2019-vol3. Italian.

PMID:
31251004
3.

A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis.

Peroni S, Sorosina M, Malhotra S, Clarelli F, Osiceanu AM, Ferrè L, Roostaei T, Rio J, Midaglia L, Villar LM, Álvarez-Cermeño JC, Guaschino C, Radaelli M, Citterio L, Lechner-Scott J, Spataro N, Navarro A, Martinelli V, Montalban X, Weiner HL, de Jager P, Comi G, Esposito F, Comabella M, Martinelli-Boneschi F.

Mult Scler. 2019 Jun 21:1352458519851428. doi: 10.1177/1352458519851428. [Epub ahead of print]

PMID:
31221001
4.

Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis.

Breccia M, Luciano L, Pugliese N, Rossi E, Tiribelli M, Scalzulli E, Bonifacio M, Martino B, Latagliata R, Benevolo G, Caocci G, Binotto G, Martinelli V, Cavo M, Pane F, De Stefano V, Foà R, Palandri F.

Ann Hematol. 2019 Aug;98(8):1933-1936. doi: 10.1007/s00277-019-03727-6. Epub 2019 Jun 14.

PMID:
31201513
5.

Reply to "Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy".

Dalla Costa G, Martinelli V, Furlan R, Comi G.

Ann Neurol. 2019 Aug;86(2):324. doi: 10.1002/ana.25526. Epub 2019 Jun 26. No abstract available.

PMID:
31187511
6.

Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis.

Dalla Costa G, Romeo M, Esposito F, Sangalli F, Colombo B, Radaelli M, Moiola L, Comi G, Martinelli V.

Mult Scler Relat Disord. 2019 Aug;33:75-77. doi: 10.1016/j.msard.2019.05.010. Epub 2019 May 21.

PMID:
31158806
7.

Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.

Pugliese N, Giordano C, Nappi D, Luciano L, Cerchione C, Annunziata M, Casale B, Crisà E, Villa MR, Pezzullo L, Iovine M, Picardi M, Grimaldi F, Pane F, Martinelli V.

Cancer Med. 2019 Jun;8(6):2802-2809. doi: 10.1002/cam4.2147. Epub 2019 Apr 17.

8.

High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation.

Rehman M, Vodret S, Braga L, Guarnaccia C, Celsi F, Rossetti G, Martinelli V, Battini T, Long C, Vukusic K, Kocijan T, Collesi C, Ring N, Skoko N, Giacca M, Del Sal G, Confalonieri M, Raspa M, Marcello A, Myers MP, Crovella S, Carloni P, Zacchigna S.

JCI Insight. 2019 Apr 18;4(8). pii: 123987. doi: 10.1172/jci.insight.123987. eCollection 2019 Apr 18.

9.

Longitudinal Phase-Space Manipulation with Beam-Driven Plasma Wakefields.

Shpakov V, Anania MP, Bellaveglia M, Biagioni A, Bisesto F, Cardelli F, Cesarini M, Chiadroni E, Cianchi A, Costa G, Croia M, Del Dotto A, Di Giovenale D, Diomede M, Ferrario M, Filippi F, Giribono A, Lollo V, Marongiu M, Martinelli V, Mostacci A, Piersanti L, Di Pirro G, Pompili R, Romeo S, Scifo J, Vaccarezza C, Villa F, Zigler A.

Phys Rev Lett. 2019 Mar 22;122(11):114801. doi: 10.1103/PhysRevLett.122.114801.

PMID:
30951354
10.

GATA-1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis.

Lally J, Boasman K, Brown L, Martinelli V, Cappuccio I, Sovani V, Marinaccio C, Crispino JD, Graham C, Rinaldi C.

J Thromb Haemost. 2019 Jun;17(6):896-900. doi: 10.1111/jth.14433. Epub 2019 Apr 25.

PMID:
30889303
11.

Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis.

Vermersch P, Martinelli V, Pfleger C, Rieckmann P, Alonso-Magdalena L, Galazka A, Dangond F, Phillips L.

Clin Ther. 2019 Feb;41(2):249-260.e18. doi: 10.1016/j.clinthera.2018.12.015.

12.

Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data.

Giordano A, Vabanesi M, Dalla Costa G, Cerri F, Comi G, Martinelli V, Fazio R.

Neurol Sci. 2019 May;40(5):1015-1018. doi: 10.1007/s10072-019-03757-y. Epub 2019 Feb 14.

PMID:
30762168
13.

Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients.

Dalla Costa G, Martinelli V, Moiola L, Sangalli F, Colombo B, Finardi A, Cinque P, Kolb EM, Haghikia A, Gold R, Furlan R, Comi G.

Ann Neurol. 2019 Apr;85(4):606-610. doi: 10.1002/ana.25437. Epub 2019 Mar 5.

PMID:
30761586
14.

Laparoscopic sleeve gastrectomy in an adolescent with Prader-Willi syndrome: psychosocial implications.

Martinelli V, Chiappedi M, Pellegrino E, Zugnoni M, Caccialanza R, Muggia C, Cogni G, Chiovato L, Bichisao G, Politi P, Pietrabissa A, Peri A.

Nutrition. 2019 May;61:67-69. doi: 10.1016/j.nut.2018.10.033. Epub 2018 Nov 7.

PMID:
30703571
15.

Living Kidney Donation Is Recipient Age Sensitive and Has a High Rate of Donor Organ Disqualifications.

Gregorini M, Martinelli V, Ticozzelli E, Canevari M, Fasoli G, Pattonieri EF, Erasmi F, Valente M, Esposito P, Contardi A, Grignano MA, Pietrabissa A, Abelli M, Rampino T.

Transplant Proc. 2019 Jan - Feb;51(1):120-123. doi: 10.1016/j.transproceed.2018.03.136. Epub 2018 Jun 30.

PMID:
30655157
16.

Psychological Aspects and Psychopharmacologic Treatment in the Very Early Period After Kidney Transplantation: Role of a Multidisciplinary Approach.

Martinelli V, Gregorini M, Politi P, Erasmi F, Contardi A, Abelli M, Ticozzelli E, Canevari M, Pietrabissa A, Chiappedi M, Rampino T.

Transplant Proc. 2019 Jan - Feb;51(1):143-146. doi: 10.1016/j.transproceed.2018.02.211. Epub 2018 Jun 30.

PMID:
30655126
17.

Brain and cord imaging features in neuromyelitis optica spectrum disorders.

Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I, Pagani E, Martinelli V, Matthews L, Drulovic J, Leite MI, Comi G, Filippi M, Rocca MA.

Ann Neurol. 2019 Mar;85(3):371-384. doi: 10.1002/ana.25411. Epub 2019 Jan 28.

PMID:
30635936
18.

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes.

Dalla Costa G, Martinelli V, Sangalli F, Moiola L, Colombo B, Radaelli M, Leocani L, Furlan R, Comi G.

Neurology. 2019 Feb 12;92(7):e733-e741. doi: 10.1212/WNL.0000000000006902. Epub 2019 Jan 11.

19.

Opportunistic salpingectomy: an appropriate procedure during all pelvic surgeries.

Nezhat FR, Martinelli VT.

Am J Obstet Gynecol. 2019 Jan;220(1):10-11. doi: 10.1016/j.ajog.2018.11.1096. No abstract available.

PMID:
30591117
20.

Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation.

Martinelli V, Dalla Costa G, Sangalli F, Colombo B, Robotti M, Moiola L, Comi G.

Mult Scler Relat Disord. 2019 Feb;28:57-59. doi: 10.1016/j.msard.2018.11.034. Epub 2018 Dec 1.

PMID:
30554038
21.

Biallelic mutations in nucleoporin NUP88 cause lethal fetal akinesia deformation sequence.

Bonnin E, Cabochette P, Filosa A, Jühlen R, Komatsuzaki S, Hezwani M, Dickmanns A, Martinelli V, Vermeersch M, Supply L, Martins N, Pirenne L, Ravenscroft G, Lombard M, Port S, Spillner C, Janssens S, Roets E, Van Dorpe J, Lammens M, Kehlenbach RH, Ficner R, Laing NG, Hoffmann K, Vanhollebeke B, Fahrenkrog B.

PLoS Genet. 2018 Dec 13;14(12):e1007845. doi: 10.1371/journal.pgen.1007845. eCollection 2018 Dec.

22.

Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: A case report.

Pisa M, Della Valle P, Coluccia A, Martinelli V, Comi G, D'Angelo A, Moiola L.

Mult Scler Relat Disord. 2019 Jan;27:403-405. doi: 10.1016/j.msard.2018.11.029. Epub 2018 Nov 29.

PMID:
30513503
23.

Focusing of High-Brightness Electron Beams with Active-Plasma Lenses.

Pompili R, Anania MP, Bellaveglia M, Biagioni A, Bini S, Bisesto F, Brentegani E, Cardelli F, Castorina G, Chiadroni E, Cianchi A, Coiro O, Costa G, Croia M, Di Giovenale D, Ferrario M, Filippi F, Giribono A, Lollo V, Marocchino A, Marongiu M, Martinelli V, Mostacci A, Pellegrini D, Piersanti L, Di Pirro G, Romeo S, Rossi AR, Scifo J, Shpakov V, Stella A, Vaccarezza C, Villa F, Zigler A.

Phys Rev Lett. 2018 Oct 26;121(17):174801. doi: 10.1103/PhysRevLett.121.174801.

PMID:
30411933
24.

Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family.

Gelibter S, Mazzi B, Tassara M, Colombo B, Guerrieri S, Giordano A, Preziosa P, Comola M, Esposito F, Martinelli V, Rocca MA, Comi G, Leocani L, Martinelli-Boneschi F.

Mult Scler Relat Disord. 2018 Oct;25:73-76. doi: 10.1016/j.msard.2018.07.017. Epub 2018 Jul 24.

PMID:
30053751
25.

Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.

Romeo MAL, Martinelli V, Dalla Costa G, Colombo B, De Feo D, Esposito F, Ferrè L, Guaschino C, Guerrieri S, Liberatore G, Martinelli Boneschi F, Merlini A, Messina M, Messina R, Nuara A, Preziosa P, Radaelli M, Rocca MA, Rodegher M, Sangalli F, Strambo D, Moiola L, Comi G.

Acta Neurol Scand. 2018 Nov;138(5):447-453. doi: 10.1111/ane.12999. Epub 2018 Jul 22.

PMID:
30033621
26.

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib.

Crisà E, Cilloni D, Elli EM, Martinelli V, Palumbo GA, Pugliese N, Beggiato E, Frairia C, Cerrano M, Lanzarone G, Marchetti M, Mezzabotta M, Boccadoro M, Ferrero D.

Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.

PMID:
29984826
27.

Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report.

Giordano A, Colombo B, Spinelli EG, Gelibter S, Guerrieri S, Leocani L, Comi G, Martinelli V.

Mult Scler Relat Disord. 2018 Aug;24:69-71. doi: 10.1016/j.msard.2018.06.011. Epub 2018 Jun 20.

PMID:
29957351
28.

Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction.

Zacchigna S, Martinelli V, Moimas S, Colliva A, Anzini M, Nordio A, Costa A, Rehman M, Vodret S, Pierro C, Colussi G, Zentilin L, Gutierrez MI, Dirkx E, Long C, Sinagra G, Klatzmann D, Giacca M.

Nat Commun. 2018 Jun 26;9(1):2432. doi: 10.1038/s41467-018-04908-z.

29.

Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.

Ferre' L, Clarelli F, Sferruzza G, Rocca MA, Mascia E, Radaelli M, Sangalli F, Dalla Costa G, Moiola L, Aboulwafa M, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V, Esposito F.

Neurol Sci. 2018 Aug;39(8):1467-1470. doi: 10.1007/s10072-018-3440-0. Epub 2018 May 13.

PMID:
29756179
30.

Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis.

Srinivasan S, Severa M, Rizzo F, Menon R, Brini E, Mechelli R, Martinelli V, Hertzog P, Salvetti M, Furlan R, Martino G, Comi G, Coccia EM, Farina C.

Sci Rep. 2018 May 11;8(1):7615. doi: 10.1038/s41598-018-24987-8.

31.

HLA-G is expressed in intestinal samples of ulcerative colitis and Crohn's disease patients and HLA-G5 expression is differentially correlated with TNF and IL-10 cytokine expression.

Gomes RG, Brito CAA, Martinelli VF, Santos RND, Gomes FODS, Peixoto CA, Crispim JO, Diniz GTN, Donadi EA, Lucena-Silva N.

Hum Immunol. 2018 Jun;79(6):477-484. doi: 10.1016/j.humimm.2018.03.006. Epub 2018 Mar 26.

PMID:
29588183
32.

Depression after a cardiac arrest: An unpredictable issue to always investigate for.

Baldi E, Vanini B, Savastano S, Danza AI, Martinelli V, Politi P.

Resuscitation. 2018 Jun;127:e10-e11. doi: 10.1016/j.resuscitation.2018.03.027. Epub 2018 Mar 16. No abstract available.

PMID:
29555262
33.

Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.

Sorosina M, Clarelli F, Ferrè L, Osiceanu AM, Unal NT, Mascia E, Martinelli V, Comi G, Benigni F, Esposito F, Martinelli Boneschi F.

Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16.

PMID:
29528549
34.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
35.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
36.

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients.

Esposito F, Ferrè L, Clarelli F, Rocca MA, Sferruzza G, Storelli L, Radaelli M, Sangalli F, Moiola L, Colombo B, Martinelli Boneschi F, Comi G, Filippi M, Martinelli V.

J Neurol. 2018 Apr;265(4):896-905. doi: 10.1007/s00415-018-8791-1. Epub 2018 Feb 12.

PMID:
29435643
37.

Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins.

Laurini E, Martinelli V, Lanzicher T, Puzzi L, Borin D, Chen SN, Long CS, Lee P, Mestroni L, Taylor MRG, Sbaizero O, Pricl S.

Cardiovasc Res. 2018 May 1;114(6):846-857. doi: 10.1093/cvr/cvy040.

38.

Changes in quality of life and functional capacity after lung transplantation: A single-center experience.

Ricotti S, Martinelli V, Caspani P, Monteleone S, Petrucci L, Dalla Toffola E, Klersy C.

Monaldi Arch Chest Dis. 2017 Dec 18;87(3):831. doi: 10.4081/monaldi.2017.831.

39.

Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience.

Cerchione C, Nappi D, Pareto AE, Romano A, Martinelli V, Picardi M, Pane F, Catalano L.

Anticancer Drugs. 2018 Apr;29(4):371-372. doi: 10.1097/CAD.0000000000000604.

PMID:
29420336
40.

Digital epidemiology confirms a latitude gradient of MS in France.

Dalla Costa G, Giordano A, Romeo M, Sangalli F, Comi G, Martinelli V.

Mult Scler Relat Disord. 2018 Feb;20:129-131. doi: 10.1016/j.msard.2018.01.009. Epub 2018 Mar 20.

PMID:
29414285
41.

Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria.

Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, Sica F, Grasso MG, Clemenzi A, Bonavita S, Esposito S, Patti F, D'Amico E, Cruccu G, Truini A; Neuropathic Pain Special Interest Group of the Italian Neurological Society.

J Neurol. 2018 Apr;265(4):828-835. doi: 10.1007/s00415-018-8758-2. Epub 2018 Feb 5.

PMID:
29404736
42.

Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.

Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G, Spagni G, Barilaro A, Repice AM, Emmi L, Prisco D, Martinelli V, Scotti R, Sadeghi N, Perrotta G, Sati P, Dachy B, Reich DS, Filippi M, Massacesi L.

Ann Neurol. 2018 Feb;83(2):283-294. doi: 10.1002/ana.25146. Epub 2018 Feb 15.

43.

Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.

Rocca MA, Riccitelli GC, Meani A, Pagani E, Del Sette P, Martinelli V, Comi G, Falini A, Filippi M.

Mult Scler. 2019 Mar;25(3):372-381. doi: 10.1177/1352458517750767. Epub 2018 Jan 5.

PMID:
29303036
44.

Cellular biomechanics impairment in keratinocytes is associated with a C-terminal truncated desmoplakin: An atomic force microscopy investigation.

Puzzi L, Borin D, Martinelli V, Mestroni L, Kelsell DP, Sbaizero O.

Micron. 2018 Mar;106:27-33. doi: 10.1016/j.micron.2017.12.005. Epub 2017 Dec 19.

PMID:
29291530
45.

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.

Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA.

Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21.

PMID:
29275979
46.

Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood.

Preziosa P, Moiola L, Baldoli C, Longo D, Sangalli F, Radaelli M, Comi G, Martinelli V, Filippi M.

J Neurol Sci. 2018 Jan 15;384:58-60. doi: 10.1016/j.jns.2017.11.032. Epub 2017 Nov 23. No abstract available.

PMID:
29249379
47.

Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice.

Dalla-Costa G, Radaelli M, Maida S, Sangalli F, Colombo B, Moiola L, Comi G, Martinelli V.

J Neurol Sci. 2017 Dec 15;383:166-168. doi: 10.1016/j.jns.2017.10.043. Epub 2017 Oct 27.

PMID:
29246607
48.

Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients.

Dalla Costa G, Finardi A, Garzetti L, Carandini T, Comi G, Martinelli V, Furlan R.

Neurol Sci. 2018 Feb;39(2):373-376. doi: 10.1007/s10072-017-3176-2. Epub 2017 Nov 28.

PMID:
29185135
49.

No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS.

Pisa M, Guerrieri S, Di Maggio G, Medaglini S, Moiola L, Martinelli V, Comi G, Leocani L.

Neurology. 2017 Dec 12;89(24):2469-2475. doi: 10.1212/WNL.0000000000004736. Epub 2017 Nov 15.

PMID:
29142087
50.

Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.

Rocca MA, Sormani MP, Rovaris M, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Laroni A, Bergamaschi R, Martinelli V, Comi G, Filippi M.

Brain. 2017 Nov 1;140(11):2814-2819. doi: 10.1093/brain/awx250.

PMID:
29053836

Supplemental Content

Loading ...
Support Center